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ABSTRACT 
Peroxisome proliferator activated receptors (PP ARs) are ligand-activated transcription 
factors that belong to the nuclear hormone receptor superfamily. Despite significant 
involvement in the lipid metabolism, little is known about the expression pattern and the 
role of different PP ARs in immune regulation. Emerging evidence suggests that PP ARs 
may act as negative immunomodulators. To provide further insight into the role ofPPARs 
in the immune system, the expression patterns of PPARa., PPARyl and PPARy2 in 
peritoneal macrophages and splenocyte-derived T lymphocyte subsets, CD4+ and CD8+ 
cells of balb/c mice were studied. 
Total RNA from each of the cell subsets was extracted, reverse-transcribed to eDNA and 
the expression of PPARa, PPARyl and PPARy2 quantified by Real-Time PCR using 
specific primers and probes. The expression levels were then calculated per J..lg total RNA 
and statistically analyzed using statistical software. In addition, cytokine expression 
profiles in the selected immune cells were also assessed using multiplex PCR method. 
The results obtained in the present study demonstrate that all the immune cell subtypes 
predominantly express PP ARyl suggesting the probable involvement of this transcription 
factor in immune response or other biological functions of these cells. The study also 
further confirms that lymphocytes express PP ARa. CD8+ lymphocytes showed the lowest 
expression of all PP AR isoforms compared to other immune cells suggesting minimal 
involvement of the PP ARs in the immune response mediated by these cells. In addition 
baseline expression levels of various cytokines in immune cell subsets in young adult mice 
also were showed in the current study. 
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INTRODUCTION 
Peroxisome 
Peroxisome is a subcellular organelle present in all human cells except mature red blood 
cells, as well as in many cells of animals, plants and fungi. There are more than 60 
peroxisomal enzymes which catalyze various biochemical reactions within the cells, 
mainly the metabolism of hydrogen peroxide, lipid synthesis and (3-oxidation of long and 
very long-chain fatty acids that cannot be oxidized by mitochondria. Thus, the importance 
of peroxisomal functions had been highlighted by the discovery of various peroxisomal 
disorders such as X-linked adrenoleukodystrophy, infantile Refsum's disease and 
Zellweger's syndrome (Wanders et.al., 1996; Suzuki et.al., 1996) 
Peroxisome Proliferators 
A number of structurally diverse substances were found to promote proliferation of 
peroxisomes. These substances are collectively named "peroxisome proliferators", which 
include fibrate hypolipidaemic drugs (e.g., bezafibrate, fenofibrate ), non-fibrate 
hypolipidaemic drugs, some non-steroidal anti-inflammatory drugs (e.g., ibuprofen), 
thiazolidinediones and leukotriene D4 receptor antagonists (Chinetti et al., 1998; Tedgui 
and Mallat, 2001 ). A rapid induction of gene expression, particularly those involved in 
fatty acid oxidation following peroxisome proliferator administration, had led to the 
discovery of receptor mediated mechanism of action. This receptor was identified and 
cloned by lssemann and Green, in 1990 from mouse liver and designated as, peroxisome 
proliferator activated receptor-a (PP AR-a.) (Zhang et a/., 2002). Additional pp AR 
subtypes, PPAR-13 and PPAR-y were subsequently identified and cloned (Dreyer et.al., 
1992). 
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PPAR Structure, Function and Distribution 
PP AR.s are ligand-activated transcription factors that belong to the nuclear hormone 
receptor superfamiliy, which include receptors for thyroid hormone, steroid hormones and 
vitamin D (Boiter et al., 2003). Basically, PPARs are composed of three distinct isoforms, 
namely PPARa, PPARf3 (also known as PPARo) and PPARy. PPARy has three splice 
variants termed PPARy1, y2 and y3 (Willson et a/., 2001; Kintscher et a/., 2002). Each 
isoform is encoded by a separate gene (Tontonaz eta/., 1994; Zhu eta/., 1993; Mukherjee 
et a/., 1997). 
PP ARs like other nuclear hormone receptors, are typically organized into five to six 
structural regions (A, B, C, D, E and F) and four functional domains (AlB, C, D, E/F) 
(Vamecq and Latruffe, 1999) (Figure 1 ). The AlB domain at the amino-terminal is 
involved in transactivation. This region is poorly conserved and most variable in length 
between the three PPAR isotypes (Boiter eta/., 2003; Kersten, 2001). The C domain is the 
DNA binding domain. It is highly conserved and consists of two zinc finger-like 
structures. 
P box in the first zinc-finger (as indicated in Figure 1) is involved in the recognition of the 
response element and the D box in the second zinc-finger is involved in dimerization 
(Wahli et a/., 1995). The D region encodes a flexible hinge region, thought to allow 
independent movement of the E/F domain relative to the C domain (Boiter eta/., 2003). 
The ElF domain is the ligand binding domain (LBD) and is responsible for ligand-binding 
which converts PP AR to an active form that binds DNA and modulates gene expression. 
In addition, the E region is essential for nuclear localization and dimerization of the 
receptor (Boiter eta/., 2003). 
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Figure 1 
Schematic representation of the domain structures of various human PP ARs. 
The numbers denote total amino acid residues in the PP AR polypeptide. 
(Wahli et al. , 1995) 
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PP ARa is highly expressed in tissues with high rate of fatty acid catabolism, as in the 
brown adipose tissue, liver, kidney and heart (Braissant, 1996). It plays an important role 
in the hepatic lipid metabolism, bile acid synthesis and control of fatty acid transport and 
uptake (Boiter et a/., 2003 ). Meanwhile, PP ARI3 is ubiquitously expressed and its function 
has largely remained an enigma. It has been proposed that PPAR(3 regulates lipid 
metabolism in nerve cells and is a mediator of fatty acid-controlled differentiation 
(Kersten, 2001 ). 
pp ARy isoform is present mainly in adipose tissue, colon and the immune system 
(Braissant, 1996), and plays an important role in adipocyte differentiation and in the 
regulation of macrophage activation (Chinetti et a/., 1998). In addition, it regulates the 
production of monocyte inflammatory responses by inhibiting the production of 
inflammatory cytokines such as IFNy, a potent macrophage activator (Jiang et al., 1998). 
Like other members of the nuclear receptor superfamily, PP ARs possess a central DNA-
binding domain that recognizes DNA sequences, termed PPAR-response elements 
(PPREs ), in the promoter regions of their target genes. PP ARs heterodimerize with another 
member of the nuclear-receptor superfamily, the retinoid X receptors {RXR), and the 
transcription regulation of target genes by PP ARs is actually achieved through the binding 
of these PPAR-RXR heterodimers to PPREs (Kliewer et.al., 1992; Mangelsdorf et.a/., 
1995; Mangelsdorf et.a/., 1990). 
RXR also exists in multiple isoforms, RXR.a, J3, and y, and like the PP ARs, have a variable 
tissue distribution (Chambon et.al., 1996; Mangelsdorf et.al., 1992). RXR isoforms are 
activated by 9-cis retinoic acid (Kliewer et.al., 1992). It is not known if any one of the 
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particular RXR isoforms preferentially binds one or more of the PP AR isoforms. RXR also 
forms heterodimers with other members of the nuclear receptor superfamily, and these 
interactions influence the PP AR-regulated transcriptional activation because of the 
competition among various RXR heterodimerization partners for RXR (Lemberger et.al . ., 
1996). In the presence of ligands for PPAR, the PPAR: RXR heterodimer does not require 
that 9-cis retinoic acid be present for transcriptional activation. 
However, when combined as PP AR: RXR heterodimer, PP AR ligands and 9-cis retinoic 
acid can act synergistically on PP AR responses (Kliewer et.al., 1992). The different 
heterodimers of RXR (e.g., PP AR: RXR) allow for specific responses by binding to highly 
specific sequences in the promoter regions of the genes they transactivate (Mangeldorf 
et.a/., 1995). 
Although the PP AR: RXR dimer is the focus for determining specific gene transcription 
on ligand activation, transactivation of a particular gene actually requires a large complex 
of proteins {Torchia et.al., 1998). Thus, the regulation of PPAR-regulated transcriptional 
activation is made more complex by the involvement of coactivators and corepressors 
(Zhu et.al., 1997; Zhu et.al., 1996). 
In the inactivated state, the PP ARs are believed to be in complexes bound with corepressor 
proteins. In this state, in some but not all cell types, PP ARs may have a cytoplasmic rather 
than a nuclear location (Chinetti et.al., 1998; Bishop-Bailey et.al., 1999). Upon ligand 
activation., PP ARs dissociate from corepressors and recruit coactivators, including the 
PP AR-binding protein (Zhu et.al., 1991) and the steroid receptor coactivator-1 (Zhu et.al., 
1996), and can translocate from the cytoplasm to the nucleus (Bishop-Bailey et.al., 1999). 
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The earliest evidence suggesting the potential role of PP AR in immune regulation came 
from the study that PP ARa.- deficient mice display a prolonged response to inflammatory 
stimuli. It was suggested that PP ARa. deficiency results in a reduced 13-oxidation of these 
inflammatory fatty acid derivatives (Chinetti et al., 2000). 
pp AR.s were shown to inhibit the activation of inflammatory response genes such as IL-2, 
IL-6, IL-8 and TNFa. by inhibiting NF-KB, STAT and AP-I signaling pathways. The 
current study aims to quantify and compare the expression of PPARa., PPARyl and 
pp ARy2 in selected immune cells of balb/c mice and to study the relationship between 
cytokine levels and PP AR expression. 
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REVIEW OF LITERATURE 
Since the discovery of the first member ofPPAR family, the role of these receptors in the 
regulation of the metabolism of lipids and lipoproteins, and in immune and inflammatoty 
responses as well as the mechanism of action involved have been extensively studied. 
Jones et.al (2002}, demonstrated that spleen-derived T cells (both CD4+ and CD8+) and B 
cells constitutively expressed PP ARa. They found that PP ARa is the predominant 
isoform expressed in lymphocytes whereas PP ARy dominates cells of the myeloid lineage 
(macro phages, dendritic cells and mast cells). 
In addition, quantification of PP ARa transcript in T lymphocytes isolated from peripheral 
lymph nodes, spleen, and Peyer's patches of normal C3H/HeN mice suggests that 
pp ARa expression in T lymphocytes may be influenced by the microenvironment of 
lymphoid organ in which the lymphocytes reside, since Peyer' s patch T cells expressed 
greater amount of PP ARa compared to those isolated from peripheral lymphoid organs in 
the study (Jones et.al., 2002). 
In 1998, Tontonoz et.al reported that PPARy might promote monocyte/macrophage 
differentiation and uptake of oxidized LDL, as the macrophages play a crucial role in 
vascular wall inflammation and atherosclerotic plug formation. The finding is further 
affinned by Chinetti et.al (1998). They reported that both PPARa. and PPARy were 
expressed in differentiated human macrophages. The study in which, a qualitative RT .. 
PCR analysis was perfonned using specific primers on RNA from freshly isolated human 
monocytes and macrophages at different stages of differentiation, revealed that pp ARa 
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expression is already detectable in monocytes and increases along the differentiation 
process into macrophages. 
By contrast, PP ARy expression is not detectable in monocytes, but is strongly induced 
upon differentiation into macro phages. Since PP ARy expression is undetectable tn 
circulating human monocytes and appears only several hours after induction of 
differentiation, it is unlikely that PP ARy is involved in the initial differentiation process 
and appears to be an important component of further downstream processes in 
macrophage differentiation and function. 
Various factors may influence the expression of different PPAR isofonns in vivo. It has 
been recently reported by Ricote et.al ( 1998), that the expression of PP ARy is up regulated 
during the differentiation of macrophage colony-stimulating factor (M-CSF) and 
granulocyte/macrophage colony-stimulating factor (GM-CSF) treated bone marrow 
progenitor cells. 
pp ARy expression was detected in the adherent macrophage population that was induced 
by M-CSF. GM-CSF also induced PPARy mRNA expression in the adherent macrophage 
population, although less strongly than M-CSF. Treatment of resident peritoneal 
macrophages with M-CSF and GM-CSF led to a marked increase in PP ARy protein levels 
(Ricote et.a/., 1998). 
Furthermore, PP ARy was also found to be highly expressed in thioglycolate-elicited 
peritoneal macrophages (Ricote et.al., 1998). These observations suggest that humoral 
factors (M-CSF and GM-CSF) that are produced during the inflammatory process 
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augment PP ARy expression. PP ARy mRNA expression was also upregulated in primary 
macrophages and THP-1 monocytic leukemia cells by the phorbol ester 12-0-
tetradecanoylphorbol 13-acetate (TPA) (Ricote et.al., 1998). 
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OBJECTIVES 
The objective of this project was to demonstrate the different expression pattern of 
PPARa, PPARyl and PPARy2 in selected immune cells; peritoneal macrophages, CD4+ 
and CD8+ lymphocytes in the animal model ofbalb/c mice under normal condition. 
Specifically, this research approach was used to: 
1. Quantify and compare the expression of the transcription factors, PP ARa., 
PPARyl and PPARy2 in selected immune cells ofbalb/c mice. 
2. Study the relationship between cytokine levels and PP AR expression tn 
selected immune cells of balb/c mice. 
The study objective will be used to demonstrate the possible involvement of different 
PPAR isoforms namely, PPARa., PPARyl and PPARy2 in selected immune cells; 
peritoneal macrophages, CD4+ and CD8+ lymphocytes. 
ll 
MATERIALS AND METHODS 
Materials 
5.1 Experimental Animals 
Male balb/c mice between 6 to 7 weeks old were used in the study. The animals were 
housed at the Universiti Sains Malaysia Animal House. All the mice were sacrificed by 
cervical dislocation 
5.2 Reagents and Kits 
Reagents and kits used in this study are listed below. 
RNeasy® Mini Kit and Qiashredder (Qiagen Inc., USA), Dynabeads® Mouse CD4 [L3T4] 
and Dynabeads® Mouse CD8 [Lyt2] (Dynal Co., Norway), TaqMan® PCR Reagent Kit 
and 2X TaqMan® Universal Master Mix, TaqMan® Probes [AB] (Applied Biosystems 
Co., USA), RevertAid TM H Minus First Strand eDNA Synthetic Kit (Fermentas, USA), 
Mouse 18S rRNA Primer Set Kit (Maxim Biotech, USA), Human Monoclonal Antibodies: 
Control IgG I PE, Control IgG 1 FITC, anti-CD3 [Leu-4] FITC, anti-CD4 [L3T4] PE, anti-
CD8 [Lyt2] PE, anti-CDI4 FITC (Becton Dickson, USA), MPCR Kit for Human 
Inflammatory Gene Set l(Maxim Biotech, USA), GeneAmp® Optical Caps, GeneAmp® 
Optical Tubes, GeneAmp® 96 Well Tray/Retainer Set, GeneAmp® Splash Free Support 
Base (Perkin Almer Cetus Corp, USA). 
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5.3 Solutions and Chemicals 
Ethanol (Merck, Germany), NaH2P04.2H20 (E. Merck, Germany), KCL (Becton Dickson., 
UK), NaCI (E. Merck, Germany), NRtCl (Becton Dickson, UK), KHCO (Becton Dickson, 
UK), Trypan Blue (Sigma, USA), Sodium Bicarbonate solution [7.5% w/v] (Sigma, USA), 
Tris base (Promega, USA), Diethyl pyrocarbonate water [DEPC] (Sigma, USA), EtBr 
powder (Sigma, USA), Agarose powder (Promega, USA), RPMI 1640 solution 
5.4 Equipments 
Dynal Magnetic Particle Concentrater [MPC-L] (Dynal Co, Denmark), Dynal Particle 
Mixer (Dynal Co, Denmark), Real-Time PCR (ABI PRIS~ 5700 Sequence Detection 
System, Applied Biosystems,USA), 15 ml Falcon tube (Becton Dickinson Labware, 
USA), Haemacytometer (Assistant, Germany), Light microscope (Leica Microsystems, 
Germany), FACScan Flow Cytometer (Becton-Dickinson, USA), Spectrophotometer 
(Eppendorf, Germany), RNase-free quartz cuvette (Eppendorf, Germany), Agarose gel 
apparatus model MGU-202T (C.B.S. Scientific Co., California), Electrophoresis power 
supply (Amersham Pharmacia Biotech, USA), UV Transilluminator {Spectroline, Model 
TC-312A, USA), Digital Image Analyzer (Amersham Pharmacia Biotech, USA), Mini 
centrifuge (National Labnet Co., Woodbridge), Perkin Elmer GeneAmp® PCR System 
2400 (Applied Biosystem, USA), ImageMaster TotalLab software (Amersham Pharmacia 
Biotech, USA), Perkin Elmer GeneAmp® PCR System 9700 (Applied Biosystem, USA), 
Primer Express Software (Applied Biosystem, USA). 
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Methods 
5.5 Reagent Preparation 
(a) 70% Ethanol 
Prepared by dissolving 70ml ethanol in 30ml deionized water. 
(b) 1 OX Phosphate Buffered Solution (PBS) 
Prepared by dissolving 1.4 g NaH2P04.2H20, 0.2g KCI and 8.1g NaCl in 800ml 
deionized water. The pH of the solution adjusted to 7.3-7.4 by 3M NaOH and made 
·up toIL by adding deionized water. The solution was then autoclaved at 121°C for 
15 minutes and stored at room temperature. A working solution was prepared by 
adding in deionized water and stored at 4 °C. 
(c) Lysis Buffer, 6X ACK 
Prepared by dissolving 49.7g NfuCl, IOO.lg KHCO and 0.222g EDTA in 800ml 
deionized water. The pH of the solution adjusted to 7.3-7.4 by 3M NaOH and made 
up to IL by adding deionized water. To prepare a working solution, the 6X ACK 
stock solution diluted by adding deionized water and the IX ACK was filtered 
through a 0.2 J.lffi pore membrane filter to sterilize the solution. 
(d) RPMI 1640 solution 
Prepared by dissolving one packet of powdered media, 2.0 grams of NaHC03 and 
4.4 miiN HCI in 300 ml ddH20. The volume was made up to IL using ddH20. The 
solution sterilized and stored at 4 °C. 
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Agarose Gel Electrophoresis (RNA) 
(e) 50x Tris-acetate buffer (TAE) 
Prepared by dissolving 12lg Tris base, 28.5ml glacial acetic acid and 50ml 0.5M 
EDTA pH 8.0 in diethyl pyrocarbonate (DEPC) water. The solution was then 
autoclaved at 121 oc for 15 minutes and stored at room temperature. A 1 x T AE 
running buffer and gel loading buffer prepared by diluting in DEPC water. 
(f) RNA loading buffer for gel electrophoresis 
Prepared by mixing 20g sucrose and 0.125g orange Gin 50ml DEPC water. 
(g) Ethidium bromide (EtBr) 
IOmg/ml EtBr solution was prepared by dissolving O.lg EtBr powder in IOml 
deionized water. The solution was kept in a dark bottle and stored at room 
temperature. 
Agarose Gel Electrophoresis (DNA) 
(b) lOx tris-borate EDTA (TBE) stock buffer 
Prepared by dissolving 54g Tris base, 27.5g boric acid and 20ml 0.5M EDTA pH 8.0 
in 500ml deionized water. The solution was then autoclaved at 121 oc for 15 minutes 
and stored at room temperature. A working solution of 0.5x TBE buffer was made 
with deionized water. 
(i) DNA loading buffer: 
Prepared by dissolving 0.125g Orange G and 20g sucrose in 50ml deionized water. 
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5.6 Experimental Procedure 
(a) Isolation of Mouse Peritoneal Macro phages and Splenocytes 
Peritoneal macrophages and splenocytes were isolated from male balb/c mice of 6-7 
weeks old. 
Peritoneal Washing 
Mouse was first sacrificed by cervical dislocation. Skin surrounding the peritoneal region 
was swabbed with 70% ethanol and was cut opened to reveal the abdominal cavity. Five 
milliliters of RPMI 1640 solution was then injected into the abdominal cavity using a 
sterile syringe and gently massaged in order to optimize the harvest. After 2 to 3 minutes, 
the RPMI solution was retrieved back into the syringe. The peritoneal washout was then 
put into a 1 Oml centrifuge tube and centrifuged at 1500 rpm for 5 minutes. The pellet 
formed was rinsed with 5 ml PBS and resuspended in 1 ml PBS. The cells were counted 
using a haemacytometer. 
Splenocytes 
After harvesting the peritoneal washout, the abdominal cavity was cut opened and the 
spleen removed and placed in a sterile petri dish containing five to six milliliters of RPMI 
1640 solution. The spleen was then disrupted mechanically using a syringe plunger and 
the homogenate was filtered using sterile cotton wool placed in a syringe. The filtrate was 
collected into a new tube and centrifuged at 1500 rpm for 5 minutes. The pellet was then 
resuspended in 5 ml of ACK ( 1 X) solution and incubated at room temperature for 5-1 o 
minutes to enable the ACK solution lyse the red cells. The suspension was then 
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centrifuged at 1500 rpm for 5 minutes and was finally resuspended in one ml PBS. The 
total splenocyte population was counted manually using haemacytometer. 
(b) Isolation of CD4+ and CDS+ Cells from Total Splenocytes 
Estimation of Dynabeads Concentration 
The antibody coated beads, Dynabeads® Mouse CD4 (L3T4) and Dynabeads® Mouse 
CDS (Lyt2) used in the present study were obtained from Dynal Inc., Denmark. One 
hundred J.d of the bead concentrate consists of 4 x 10 7 beads. The maximum binding 
capacity of the RNeasy column is 100 Jlg RNA and only 1.0 x 107 cells (maximum starting 
material) were used in order to obtain high yield and pure RNA. Therefore, in the 
experiment one hundred J.Ll of the bead concentrate was used in the study. The volume of 
cell suspension to be added to the beads concentrate calculated. 
Washing and Preparation of the Dynabeads 
One hundred J.d of Dynabeads concentrate was pi petted into a tube and was placed in the 
Dynal Magnetic Particle Concentrator (Dynal Inc., Denmark). The beads were allowed to 
settle for 2 minutes a room temperature. The supernatant was removed carefully to avoid 
removal of the beads from the tube. One ml of PBS was then added to the beads and again 
allowed to settle for 2 minutes. The supernatant was discarded and the splenocyte 
suspension added into the tube. 
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Extraction of CD4+ and CDS+ Lymphocytes 
A constant amount of 3.5 x 107 splenocytes was used for sorting T-helper (CD4+) and T-
cytotoxic (CDS+) cells using dynabeads (positive selection). The volume of splenocytes 
containing 3.5 x 107 cells was calculated from the total spelenocyte population and 
pipetted into washed Dynabeads® Mouse CD4 (L3T4) concentrate in a tube. The mixture 
was mixed well and was then incubated for I hour in the cold room (on a rotor). 
After 1 hour, the tube was placed in the Dynal Magnetic Particle Concentrator and allowed 
to settle for 2 minutes ( CD4+ cells in the suspension will specifically bind to the 
Dynabeads® Mouse CD4 (L3T4) beads). 
The supernatant was carefully transferred to avoid the removal of bead -CD4+ complexes 
and unbound beads into new a tube. The pellet (bead-CD4+ complexes and unbound 
beads) was washed with one ml of PBS and centrifuged at 1500 rpm for 5 minutes. The 
pellet was then resuspended in one ml PBS and kept on ice or refrigerated. Cells in the 
supernatant removed earlier was counted using haemacytometer. The supernatant was then 
added to washed Dynabeads® Mouse CD8 (Lyt2) concentrate. The mixture was incubated 
for 1 hour in the cold room (on a rotor). 
After 1 hour, the tube was placed in the Dynal Magnetic Particle Concentrator and allowed 
to settle for 2 minutes (CDS+ cells in the suspension will specifically bind to the 
Dynabeads® Mouse CD8 (Lyt2) beads). The supernatant was carefully transferred to 
avoid the removal of bead -CDS+ complexes and unbound beads into new tube. The pellet 
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(bead-CD8+ complexes and unbound beads) was washed with one ml of PBS and 
centrifuged at 1500 rpm for 5 minutes. The pellet was then resuspended in one ml PBS 
and kept on ice or refrigerated. Once again, cell count \Vas perfonned using 
haemacytometer. The suspension was then kept on ice or refrigerated. 
(c) Flowcytometry Analysis 
Flowcytometry analysis was employed to enumerate the percentage of CD4-positive and 
COS-positive lymphocytes from the total splenocytes harvested. Flow cytometry analysis 
was carried out using monoclonal antibodies labeled with fluorescent dyes .specific for 
mononuclear cell surface antigens. Fluorescein isothiocyanate (FITC) and phycoerythrin 
(PE) labeled monoclonal antibodies that emit green and orange fluorescence respectively 
were used. A total of I 0 J.ll antibodies conjugated with FITC or PE were added into 
labeled 5 ml polystyrene round-bottom tube as shown in Table I. Fifty J.ll of cell 
suspension was added into each tube, mixed well and incubated in the dark for 30 minutes. 
All4 tubes were centrifuged at 1500 rpm for 5 minutes. After centrifugation, supernatants 
were then discarded and the pellets were washed with 2 ml PBS. The cells were fixed in 
200 f.ll PBS and analyzed using the FACScan flowcytometer (Becton-Dickson, USA). 
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Tube FITC PE 
1 Ig Gl IgGI 
2 CD3 CD4 
3 CD3 CD8 
4 CD14 
Table 1 
Fluorescence dye labeled mouse monoclonal antibodies used tn flowcytometry 
analysis 
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(d) Total RNA extraction 
The RNA extraction procedure was perfonned in a RNAse-minimized environment using 
reagents supplied in the commercial kit, RNeasy Mini Kit., (Qiagen, USA). A maximum 
of 100 Jlg of RNA longer than 200 bases can be extracted using the RNeasy Mini Kit. The 
kit consists of 3 reaction buffers namely RL T buffer, RPE buffer and RWI buffer together 
with RNeasy mini spin columns. 
The RNeasy mini spin columns contain silica gel-based 
membrane that facilitate total RNA binding during the extraction. Before starting the 
procedure, (3-mercaptoethanol was added into the RLT buffer (lOJ.!l of (3-mercaptoethanol 
per ml buffer and ethanol in the ratio of 1:4 was added to the RPE buffer). 
The peritoneal macrophages, CD4+ and CDS+ lymphocytes harvested were lysed directly 
by adding RLT buffer (600 Jll for 5 x 106-1 x 107 cells, 350 Jll for cells <5 x 106) with 
added J3-mercaptoethanol. The lysates were then passed through a 21-G needle fitted to a 3 
ml syringe for about 5-10 times and were then transferred into separate 1.5 ml collection 
tubes. Following to this, one volume of 70% (v/v) ethanol was added to the homogenized 
lysate and mixed well by pipetting. 
The mixtures were then applied onto the RNeasy mini spin columns placed in a 2 ml 
collection tube and centrifuged for 15 second at 10 OOOg. The flow-through in the 
collection tube was discarded and 700 J • .tl of RWI buffer was added to the RNeasy mini 
spin columns and centrifuged for 15 second at 10 000 rpm to wash the columns. The flow-
through together with the collection tube was then discarded. The RNeasy columns were 
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then transferred into a new 2 ml collection tube and 500 J.d of RPE buffer was pipetted 
into the RNeasy column and centrifuged for 15 second at 10 000 rpm. The flow-through 
was discarded and another 500 J.Ll of RPE buffer was then added into the RNeasy column 
and centrifuged for 2 minutes at maximum speed (12 000 rpm). 
Following centrifugation, the RNeasy column transferred into a new 1.5 ml collection 
tube. Finally, to elute the total RNA that was bound to the gel membrane of the spin 
column, 40J.Ll of RNase-free water was directly pi petted onto the RNeasy membrane and 
centrifuged for 1 minute at 10 000 rpm. Purified RNA stored at -70°C until used. 
(e) Agarose Gel Electrophoresis (RNA Analysis) 
The integrity and size distribution of total RNA can be checked by agarose gel 
electrophoresis and ethidium bromide staining. The respective ribosomal bands should 
appear as sharp bands on the stained gel. If the ribosomal bands are not sharp, but appear 
as a smear of smaller sized RNA's, it is likely that the RNA sample suffered major 
degradation during preparation. One % agarose gel was prepared by dissolving 0.4g 
agarose powder in 40ml 1x TAE buffer and boiled in a microwave oven. The gel solution 
was then cooled to 55°C in the water bath and subsequently 2J.ll of lOmg/ml EtBr was 
added to the mixture. The gel mixture was poured on washed (DEPC water) gel caster that 
had been assembled with a comb and left to harden at room temperature for 20-30 
minutes. Meanwhile, RNA sample was prepared by mixing 1 J..l.l RNA 1 X loading buffer 
with 5 J.ll total RNA and loaded into the wells on the gel. 
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The gel was run at 70 volt for about 1 Y2 hour in 1 X T AE buffer. Two sharp and clear RNA 
bands that are 28S rRNA and 18S rRNA respectively should appear on the stained gel. 
The bands formed were visualized under the UV light (UV Translluminator, Spectroline, 
USA) and the image was captured using digital image analyzer. 
(t) Spectrophotometry Analysis 
Quantitation of RNA 
The concentration of the total RNA in aqueous solutions was determined by measuring the 
absorbance at 260 nm (A260) using a spectrophotometer (Biophotometer., Eppendorf, 
Germany). An absorbance of I unit at 260 nm corresponds to 40 Jlg of RNA per ml. The 
RNA sample was first diluted with Rnase-free water (2J.Ll RNA in 99J.LI RNase free-water). 
The readings should be greater than 0.18. 
Puritv of RNA 
The ratio of readings at 260 nm and 280 nm (A26of A2so) gives an estimate of the purity of 
RNA with respect to DNA and protein contaminants. Pure solution of RNA has a peak 
absorbance at 260 nm and a 260:280 absorbance ratio within the range 1.8-2.0 (Sambrook 
et a/. 2000). However, if protein or DNA, or both are present in the sample, the ratio will 
drop to about 1 or lower. If the impurities were acceptably small, the RNA could be used 
in the next steps. 
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(g) First strand eDNA synthesis 
Extracted RNA samples in this study, were reverse-transcribed to full-length first strand 
eDNA using the RevertAid™ H Minus First Strand eDNA Synthetic Kit (MBI Fermentas, 
USA). The kit enabled reverse-transcription of up to 5 J..Lg of total RNA. The kit consist of 
the following reagents: 
• RevertAid™ H Minus M-MuL V Reverse Transcriptase (200u/J..Ll) 
• Ribonuclease Inhibitor (20u/J..Ll) 
• 5X Reaction Buffer 
• 1 OmM dNTP Mix 
• Oligo( dT)ts Primer 
• Control RNA 
• Control Primer 
• Deionized Water, nuclease free 
Oligo(dT)18 primer was used as primer in this study to enable only mRNA's with 3'-poly 
(A) tail to act as templates for eDNA synthesis, since the primer is complementary to the 
3 '-end of poly( A) mRNA. Initially, the following mixture of 5Jlg- 2 J..Lg of total RNA, 0.5 
J..Lg oligo(dT)18 primer and nuclease-free deionized water were prepared in a RNase-free 
1.5 ml microcentrigfuge tube on ice. 
The mixture was gently mixed and spun down for about 3-5 seconds. The mixture was 
then incubated at 70°C for 5 minutes. The mixture was chilled on ice and briefly 
centrifuged. Four J..Ll of 5X reaction buffer, 1 J.d of ribonuclease inhibitor and 2 Jll of 
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